Vision Capital Management, Inc. Geron Corp Transaction History

Vision Capital Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 Apr 14, 2020	SELL	$0.89 - $1.49 $16,465 - $27,565	-18,500 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$1.27 - $1.54 $23,495 - $28,490	18,500 New	18,500 $25,000

274

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.26B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Vision Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Vision Capital Management, Inc. with notifications on news.